UNSPSC 85651304: Revision of autologous tissue substitute in lower muscle, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in lower muscle, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0KWY37Z

UNSPSC 85651304 Revision of autologous tissue substitute in lower muscle, percutaneous approach (Commodity) shows no recent state and local procurement activity aligned with its medical-procedure scope. The six opportunities posted since mid-July 2026 and tagged under this code—independent medical evaluations for pension-board disability determinations, surgical Center of Excellence benefit carve-outs, occupational health surveillance, youth detention healthcare services, pharmacy benefit management, and temporary health professional staffing—do not involve autologous tissue revision procedures, orthopedic surgical repair, or related implant-based treatment. The code appears to be a misclassification artifact in state and local opportunity databases rather than an active procurement category.

Without recent opportunities that match the code's nominal scope, no issuing-body concentration, geographic spread, or representative solicitations can be characterized against the commodity itself. Firms pursuing contracts involving autologous tissue-based surgical procedures, musculoskeletal revision surgery, or percutaneous orthopedic interventions should verify code alignment directly with individual state procurement offices before relying on UNSPSC 85651304 as a search or monitoring criterion.